Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Healthtrust
Fish and Richardson
UBS
Novartis
Harvard Business School
Boehringer Ingelheim
Express Scripts
US Department of Justice
Baxter

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,303,991

« Back to Dashboard

Which drugs does patent 8,303,991 protect, and when does it expire?


Patent 8,303,991 protects SEEBRI and UTIBRON and is included in two NDAs.

This patent has one hundred and ninety-six patent family members in thirty-five countries.

Summary for Patent: 8,303,991

Title:Method of making particles for use in a pharmaceutical composition
Abstract: The invention relates to a method for making composite active particles for use in a pharmaceutical composition for pulmonary administration, the method comprising a milling step in which particles of active material are milled in the presence of particles of an additive material which is suitable for the promotion of the dispersal of the composite active particles upon actuation of an inhaler. The invention also relates to compositions for inhalation prepared by the method.
Inventor(s): Staniforth; John (Bath, GB), Green; Matthew Michael James (Surrey, GB), Morton; David Alexander Vodden (Bath, GB)
Assignee: Vectura Limited (Wiltshire, GB)
Application Number:12/767,530
Patent Claim Types:
see list of patent claims
Composition; Delivery; Device;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sunovion Pharms Inc
SEEBRI
glycopyrrolate
POWDER;INHALATION207923-001Oct 29, 2015RXYesYes► Subscribe► SubscribeY
Sunovion Pharms Inc
UTIBRON
glycopyrrolate ; indacaterol maleate
POWDER;INHALATION207930-001Oct 29, 2015RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 8,303,991

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,541,022Pharmaceutical formulations for dry powder inhalers► Subscribe
9,351,928Method of making particles for use in a pharmaceutical composition► Subscribe
8,932,635Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation► Subscribe
8,580,306Particles for use in a pharmaceutical composition► Subscribe
9,585,839Particles for use in a pharmaceutical composition► Subscribe
6,884,794 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets► Subscribe
8,029,768Treatment of respiratory diseases► Subscribe
8,871,274Pharmaceutical formulations for dry powder inhalers► Subscribe
8,048,451Pharmaceutical compositions for inhalation► Subscribe
9,566,239Pharmaceutical formulations for dry powder inhalers► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,303,991

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Cyprus1112338► Subscribe
Cyprus1115304► Subscribe
Cyprus1117749► Subscribe
Czech Republic20023437► Subscribe
Czech Republic301904► Subscribe
Germany60120936► Subscribe
Germany60123031► Subscribe
Germany60125344► Subscribe
Germany60128902► Subscribe
Germany60131265► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Federal Trade Commission
Daiichi Sankyo
Accenture
US Department of Justice
Argus Health
Fish and Richardson
Express Scripts
Moodys
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot